vimarsana.com
Home
Live Updates
Fixed Venetoclax Dosing May Not Be Feasible for All Patients
Fixed Venetoclax Dosing May Not Be Feasible for All Patients
Fixed Venetoclax Dosing May Not Be Feasible for All Patients With CLL
The retrospective cohort study evaluated data from 116 patients who received venetoclax as part of their first-line treatment and 145 patients in the relapsed/refractory setting..
Related Keywords
United States ,
,
Journal Of The National Comprehensive Cancer Network ,
Astrazeneca Pharmaceuticals ,
National Comprehensive Cancer ,
Metrics Plus ,
Southern United ,